The preclinical study (the efficacy of immunotherapy through PDO-immune cell co-culture system, the safety of immunotherapy through PDOX-immune reconstruction)

Biomarker exploration (Patient selection, Expand the indications of immunotherapy, Extensive exploratory analyses of tumor biomarkers of adaptive immunity)